ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 147 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2024. The put-call ratio across all filers is 1.09 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $10,691,384 | -20.7% | 2,360,129 | 0.0% | 0.80% | -39.9% |
| Q4 2023 | $13,476,337 | +24.1% | 2,360,129 | 0.0% | 1.32% | +10.1% |
| Q3 2023 | $10,856,593 | -33.3% | 2,360,129 | -6.3% | 1.20% | -15.5% |
| Q2 2023 | $16,279,200 | -14.3% | 2,520,000 | 0.0% | 1.42% | -9.1% |
| Q1 2023 | $19,000,800 | -17.4% | 2,520,000 | +11.0% | 1.56% | -12.2% |
| Q4 2022 | $22,995,100 | +40.9% | 2,270,000 | +37.6% | 1.78% | +66.2% |
| Q3 2022 | $16,319,000 | +104.3% | 1,650,000 | +120.0% | 1.07% | +58.8% |
| Q2 2022 | $7,988,000 | -0.7% | 750,000 | +275.0% | 0.68% | +183.6% |
| Q4 2020 | $8,048,000 | – | 200,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $28,452,416 | 91.13% |
| Founders Fund Growth Management, LLC | 407,017 | $3,068,908 | 14.23% |
| Gruss & Co., LLC | 167,500 | $1,262,950 | 7.99% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $30,952,416 | 3.25% |
| Belmont Capital, LLC | 510,000 | $3,845,400 | 3.18% |
| Prosight Management, LP | 753,528 | $5,681,601 | 2.69% |
| Intellectus Partners, LLC | 872,483 | $6,578,520 | 2.08% |
| Casdin Capital, LLC | 2,520,000 | $19,000,800 | 1.56% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $13,022,958 | 1.50% |
| Orbimed Advisors | 4,180,768 | $31,522,991 | 0.62% |